Thomas Miller

622 total citations
17 papers, 469 citations indexed

About

Thomas Miller is a scholar working on Molecular Biology, Nutrition and Dietetics and Infectious Diseases. According to data from OpenAlex, Thomas Miller has authored 17 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Nutrition and Dietetics and 5 papers in Infectious Diseases. Recurrent topics in Thomas Miller's work include Vitamin C and Antioxidants Research (5 papers), Biochemical and Molecular Research (4 papers) and Hepatitis B Virus Studies (4 papers). Thomas Miller is often cited by papers focused on Vitamin C and Antioxidants Research (5 papers), Biochemical and Molecular Research (4 papers) and Hepatitis B Virus Studies (4 papers). Thomas Miller collaborates with scholars based in Japan, United States and Bulgaria. Thomas Miller's co-authors include Robert W. King, Stephanie K. Ladner, Dennis H. Flint, Michaël Otto, Rumiana Bakalova, Zhivko Zhelev, Ichio Aoki, Tatsuya Higashi, Robert B. Perni and Katie Zaifert and has published in prestigious journals such as Journal of Biological Chemistry, Nature Neuroscience and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Thomas Miller

17 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Miller Japan 11 207 179 158 99 75 17 469
Anna Ballard United States 10 67 0.3× 42 0.2× 154 1.0× 58 0.6× 9 0.1× 14 397
H Koch Germany 9 68 0.3× 80 0.4× 282 1.8× 16 0.2× 79 1.1× 29 630
Huixing Feng Singapore 13 83 0.4× 43 0.2× 293 1.9× 13 0.1× 12 0.2× 22 498
Alex Shnyra Russia 10 50 0.2× 59 0.3× 102 0.6× 15 0.2× 20 0.3× 18 396
Azita Tabrizi United States 7 71 0.3× 103 0.6× 178 1.1× 5 0.1× 106 1.4× 9 395
Ching‐Shu Suen Taiwan 13 88 0.4× 44 0.2× 278 1.8× 24 0.2× 12 0.2× 22 492
Miho Hayashi Japan 7 80 0.4× 84 0.5× 86 0.5× 3 0.0× 110 1.5× 30 307
Demetra Mavri‐Damelin South Africa 11 60 0.3× 111 0.6× 155 1.0× 10 0.1× 19 0.3× 15 405
Heba Bassiony Egypt 10 35 0.2× 56 0.3× 79 0.5× 29 0.3× 17 0.2× 21 333

Countries citing papers authored by Thomas Miller

Since Specialization
Citations

This map shows the geographic impact of Thomas Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Miller more than expected).

Fields of papers citing papers by Thomas Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Miller. The network helps show where Thomas Miller may publish in the future.

Co-authorship network of co-authors of Thomas Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Miller. A scholar is included among the top collaborators of Thomas Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Miller. Thomas Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sumiyoshi, Akira, S. Shibata, Zhivko Zhelev, et al.. (2022). Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State. Cancers. 14(3). 485–485. 17 indexed citations
2.
Sumiyoshi, Akira, S. Shibata, Zhivko Zhelev, et al.. (2021). Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug – Comparison With the Chemotherapeutic Standard-of-care Temozolomide. Anticancer Research. 41(12). 6067–6076. 6 indexed citations
3.
Miller, Thomas, et al.. (2020). Intra-operative anaesthetic management of older patients undergoing liver surgery. European Journal of Surgical Oncology. 47(3). 545–550. 1 indexed citations
4.
Miller, Thomas, Peter Groom, & M. Stacey. (2020). Using cognitive psychology to optimise surgical cricothyroidotomy training.. Trends in Anaesthesia and Critical Care. 30. e53–e53. 1 indexed citations
5.
Bakalova, Rumiana, Donika Ivanova, Zhivko Zhelev, et al.. (2020). Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant. Oxidative Medicine and Cellular Longevity. 2020. 1–30. 24 indexed citations
6.
Zhelev, Zhivko, Thomas Miller, Kimio Sugaya, et al.. (2020). Menadione/Ascorbate Induces Overproduction of Mitochondrial Superoxide and Impairs Mitochondrial Function in Cancer: Comparative Study on Cancer and Normal Cells of the Same Origin. Anticancer Research. 40(4). 1963–1972. 18 indexed citations
7.
Bakalova, Rumiana, Zhivko Zhelev, Thomas Miller, Ichio Aoki, & Tatsuya Higashi. (2020). Vitamin C versus Cancer: Ascorbic Acid Radical and Impairment of Mitochondrial Respiration?. Oxidative Medicine and Cellular Longevity. 2020. 1–12. 28 indexed citations
8.
Khanal, Nabin, Maitri Kalra, Thomas Miller, et al.. (2019). The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy. Supportive Care in Cancer. 28(7). 3165–3170. 4 indexed citations
9.
Bakalova, Rumiana, Zhivko Zhelev, Thomas Miller, Ichio Aoki, & Tatsuya Higashi. (2019). New potential biomarker for stratification of patients for pharmacological vitamin C in adjuvant settings of cancer therapy. Redox Biology. 28. 101357–101357. 23 indexed citations
10.
Thompson, Alex J., Michael Hughes, Salzitsa Anastasova, et al.. (2017). The potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction. Nature Reviews Gastroenterology & Hepatology. 14(12). 727–738. 20 indexed citations
11.
Finkelstein, Robert, Thomas Miller, & Robert P. Baughman. (2002). The challenge of translational research—a perspective from the NINDS. Nature Neuroscience. 5(S11). 1029–1030. 8 indexed citations
12.
Ladner, Stephanie K., et al.. (1999). Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β- l -2′,3′-Dideoxy-3′-Thiacytidine. Antimicrobial Agents and Chemotherapy. 43(3). 726–726. 1 indexed citations
13.
King, Robert W., Stephanie K. Ladner, Thomas Miller, et al.. (1998). Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β- l -2′,3′-Dideoxy-3′-Thiacytidine. Antimicrobial Agents and Chemotherapy. 42(12). 3179–3186. 121 indexed citations
14.
Ladner, Stephanie K., Thomas Miller, & Robert W. King. (1998). The M539V Polymerase Variant of Human Hepatitis B Virus Demonstrates Resistance to 2′-Deoxy-3′-Thiacytidine and a Reduced Ability to Synthesize Viral DNA. Antimicrobial Agents and Chemotherapy. 42(8). 2128–2131. 32 indexed citations
15.
Ladner, Stephanie K., Thomas Miller, Michaël Otto, & Robert W. King. (1998). The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues.. PubMed. 9(1). 65–72. 52 indexed citations
16.
Flint, Dennis H., et al.. (1996). Studies on the Synthesis of the Fe-S Cluster of Dihydroxy-acid Dehydratase in Escherichia coli Crude Extract. Journal of Biological Chemistry. 271(27). 16053–16067. 100 indexed citations
17.
Walters, John D., et al.. (1995). Polyamines Found in Gingival Fluid Inhibit Chemotaxis by Human Polymorphonuclear Leukocytes In Vitro. Journal of Periodontology. 66(4). 274–278. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026